Digital Slide Imaging Evaluated for Cervicovaginal Cytology
|
By LabMedica International staff writers Posted on 26 Jun 2013 |
|
Image: BioImagene digital scanner (Photo courtesy of Ventana Medical Systems).
Digital imaging is the creation, storage, and transmission of an image file using a computer and is considered by many to be the future of anatomic pathology.
Whole slide imaging has been successfully used in surgical pathology, but its usefulness and clinical application have been limited in cytology for several reasons, including lack of availability of z-axis depth focusing and large file size.
Cytopathologists at The Methodist Hospital (Houston, TX, USA) investigated the accuracy and efficiency of whole slide imaging, as compared with traditional glass slides, for use in cervicovaginal diagnostic cytology. Eleven cervicovaginal cytology cases were evaluated by four cytotechnologists and three cytopathologists in a blinded study. Digitally scanned images were reviewed first, and different magnification scans were presented as separate cases in a random order. Corresponding glass slides were also reviewed and for each case, the diagnoses and total time to reach each diagnosis were recorded.
The specimens were prepared using both ThinPrep (BD Diagnostics TriPath; Burlington, NC, USA) and SurePath (Hologic Inc.; Marlborough, MA, USA). All the cases were scanned using the BioImagene iScan Coreo Au 3.0 scanner (Ventana Medical Systems Inc.; Sunnyvale, CA, USA). Diagnostic accuracy was higher and average time per case was lower with glass slides as compared with all digital images. Accuracy of interpretation of the digital images was best achieved with ×40 magnification, and z-stack digital images scanned at ×40 magnification improved the accuracy of diagnosis in one case of adenocarcinoma of the endometrium.
The authors concluded that whole slide imaging is a viable option for the purposes of teaching and consultations, and as a means of archiving cases. However, considering the large file size and total time to reach diagnosis on digital images, they consider whole slide imaging may not yet be ready as a daily screening tool in cervicovaginal diagnostic cytology. The study was published in the May 2013 edition of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
The Methodist Hospital
BD Diagnostics
Ventana Medical Systems
Whole slide imaging has been successfully used in surgical pathology, but its usefulness and clinical application have been limited in cytology for several reasons, including lack of availability of z-axis depth focusing and large file size.
Cytopathologists at The Methodist Hospital (Houston, TX, USA) investigated the accuracy and efficiency of whole slide imaging, as compared with traditional glass slides, for use in cervicovaginal diagnostic cytology. Eleven cervicovaginal cytology cases were evaluated by four cytotechnologists and three cytopathologists in a blinded study. Digitally scanned images were reviewed first, and different magnification scans were presented as separate cases in a random order. Corresponding glass slides were also reviewed and for each case, the diagnoses and total time to reach each diagnosis were recorded.
The specimens were prepared using both ThinPrep (BD Diagnostics TriPath; Burlington, NC, USA) and SurePath (Hologic Inc.; Marlborough, MA, USA). All the cases were scanned using the BioImagene iScan Coreo Au 3.0 scanner (Ventana Medical Systems Inc.; Sunnyvale, CA, USA). Diagnostic accuracy was higher and average time per case was lower with glass slides as compared with all digital images. Accuracy of interpretation of the digital images was best achieved with ×40 magnification, and z-stack digital images scanned at ×40 magnification improved the accuracy of diagnosis in one case of adenocarcinoma of the endometrium.
The authors concluded that whole slide imaging is a viable option for the purposes of teaching and consultations, and as a means of archiving cases. However, considering the large file size and total time to reach diagnosis on digital images, they consider whole slide imaging may not yet be ready as a daily screening tool in cervicovaginal diagnostic cytology. The study was published in the May 2013 edition of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
The Methodist Hospital
BD Diagnostics
Ventana Medical Systems
Gold Member
Aspiration System
VACUSAFE
Rapid Sepsis Test
SeptiCyte RAPID
Electrolyte Analyzer
BKE-B
Latest Pathology News
- Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
- Study Highlights Biomarker Testing Delays in Lung Cancer Care
- Stain-Free Imaging Platform Matches Standard Cancer Pathology
- New Companion Diagnostic Expands Precision Medicine in Prostate Cancer
- Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
- AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
- IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
- AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides
- 3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
- Blood-Based Method Tracks Gene Activity in the Living Brain
- FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors
- AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
- AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
- Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
- AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
- FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Channels
Clinical Chemistry
view channel
FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
Chronic liver disease contributes substantially to mortality, and clinicians routinely screen adults with compensated cirrhosis for varices to prevent bleeding. However, endoscopy is invasive and reso... Read more
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read more
Molecular Diagnostics
view channel
Genomic Assays Predict Anthracycline Benefit in Early-Stage Breast Cancer
Anthracycline-based chemotherapy remains a cornerstone of treatment for early-stage, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer, but its risks of cardiotoxicity... Read more
Gene Expression Test Refines Melanoma Biopsy Decision-Making
Sentinel lymph node biopsy (SLNB) is central to melanoma staging, yet most procedures are negative and some patients experience surgery-related complications. Clinicians need decision-support tools that... Read more
Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers
Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more
Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease
Women show distinct susceptibility to infectious diseases and higher rates of autoimmune disorders, yet the molecular drivers remain unclear. This gap has limited sex-specific diagnostic and prognostic tools.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read more
Immunology
view channel
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Severe traumatic injury can trigger immune and organ dysfunction that complicates recovery in the intensive care unit. A subset of patients develop chronic critical illness, defined as dependence on intensive... Read more
New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease
Autoimmune disorders arise when immune responses target self-antigens, driving chronic inflammation and long-term morbidity. In primary Sjögren disease, inflammation of salivary and lacrimal glands leads... Read more
Microbiology
view channel
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read more
Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more
Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more
Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more
Industry
view channel
Agilent Strengthens Pathology Capabilities Through Biocare Acquisition
Agilent Technologies has completed its acquisition of Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners LLP. Biocare is now part of Agilent’s Life Sciences and Diagnostics... Read more
